Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP19A1 | P11511 | 18/20 | 0.66 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.41 |
| ▸ | CYP3A5 | P20815 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8697223 | 0.87 | CYP19A1 (0.56) | CYP19A1 | |
| SCHEMBL8700104 | 0.86 | CYP19A1 (0.45) | CYP19A1CYP3A4 | |
| SCHEMBL8702199 | 0.85 | CYP19A1 (0.45) | CYP19A1 | |
| SCHEMBL8700017 | 0.82 | CYP19A1 (0.42) | CYP19A1CYP3A4CYP3A5 | |
| SCHEMBL8697420 | 0.79 | CYP19A1 (0.66) | CYP19A1CYP3A4CYP3A5 | |
| SCHEMBL8699069 | 0.74 | CYP19A1 (0.57) | CYP19A1CYP3A4CYP3A5 | |
| SCHEMBL8699061 | 0.74 | CYP19A1 (0.57) | CYP19A1 | |
| SCHEMBL8697427 | 0.72 | CYP19A1 (0.42) | CYP19A1CYP3A4CYP3A5 | |
| SCHEMBL8697496 | 0.68 | AR (0.41) | CYP19A1CYP3A4CYP3A5 | |
| SCHEMBL8700111 | 0.68 | CYP3A4 (0.46) | CYP19A1CYP3A4CYP3A5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-1998018791-A1 | HETEROCYCLIC FURAN COMPOUNDS, THEIR PREPARATION AND USE AS AROMATASE INHIBITORS | A. MENARINI INDUSTRIE FARMACEUTICHE RIUNITE S.R.L. (IT) | 1998-05-07 | — | — | WO | claimed |
| WO-1998018791-A1 | HETEROCYCLIC FURAN COMPOUNDS, THEIR PREPARATION AND USE AS AROMATASE INHIBITORS | A. MENARINI INDUSTRIE FARMACEUTICHE RIUNITE S.R.L. (IT) | 1998-05-07 | — | — | WO | disclosed |